Abiopharma

Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference

Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Avantor, Inc. - Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference

GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill

Sonida Senior Living Announces $900 Million of Permanent Debt Financing Commitments in Connection with CNL Healthcare Properties, Inc. Strategic Merger

Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill

The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)

Edgewise Therapeutics - Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

CoyaTherapeutics - Coya Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Frontotemporal Dementia (FTD)